Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047568 | SCV001211533 | uncertain significance | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 573 of the GUCY2D protein (p.Ile573Val). This variant is present in population databases (rs61749756, gnomAD 0.004%). This missense change has been observed in individual(s) with Leber congenital amaurosis (PMID: 16123401). ClinVar contains an entry for this variant (Variation ID: 98547). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV004815023 | SCV005072853 | uncertain significance | Retinal dystrophy | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000084840 | SCV000116976 | not provided | not provided | no assertion provided | not provided |